Organization: Health Canada
Year: 2023
Month: October
Request Number: A-2023-000458
Request Summary: The disclosable inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs drug establishment licence Good Manufacturing Practices (GMP) inspection of the Apotex facility on Signet Drive, Toronto, Ontario starting around 5 June 2017. Reference Number 501259.
Disposition: Disclosed in part
Number of pages: 9